SEC Form 3 · accession 0001250853-17-000040
LIXTE BIOTECHNOLOGY HOLDINGS, INC. · NMAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hung Tak Ho
10% Owner
Period of report
Apr 6, 2017
Accepted (ET)
Apr 17, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 6,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.